MedTrace Logo

The Purpose is to Evaluate Visual Acuity for Distance, Intermediate and Near and Additionally Contrast Sensitivity at 25% and 10% of Illumination After Implantation of Trifocal IOL, Extended Range of Vision IOL, Bifocal IOL With Low Addition and Monofocal IOL

NCT07008768 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 131

Last updated 2025-06-12

No results posted yet for this study

Summary

The objective of this study was to evaluate the effect of intraocular lens (IOL) selection on visual acuity and refractive outcomes, to assess the impact of IOL type on postoperative contrast sensitivity, and to investigate whether IOL choice influences the induction and dynamics of higher-order ocular aberrations following cataract surgery/refractive lens exchange surgery in hyperopic patients.

Conditions

  • Cataract
  • Presbyopia Correction
  • Visual Acuity

Interventions

PROCEDURE

Cataract surgery and refractive lens exchange surgery

Cataract surgery or refractive lens exchange surgery was performed with standard phacoemulsification procedure using micro coaxial surgical technique. After superior clear corneal incision, anterior capsulorexis and lens phacoemulsification, the IOL was implanted into the capsular bag using an injector in all cases. Ophthalmic Viscosurgical Device (OVD) was completely removed by irrigation and aspiration. All incisions were self-closing.

DEVICE

TRIFOCAL IOL

1-piece aspheric hydrophobic presbyopia-correcting intraocular lens, trifocal

DEVICE

EROV IOL

1-piece aspheric hydrophobic presbyopia-correcting intraocular lens, extended range of vision (EROV)

DEVICE

BIFOCAL IOL

1-piece aspheric hydrophobic presbyopia-correcting intraocular lens, bifocal with low addition

DEVICE

MONOFOCAL IOL

Control lens: 1-piece aspheric hydrophobic monofocal aspheric IOL

Sponsors & Collaborators

  • University Eye Hospital Svjetlost

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2020-10-31
Completion
2022-03-30

Countries

  • Croatia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07008768 on ClinicalTrials.gov